Jeffrey Kerlan, MD
Clinical Cardiac Electrophysiology · Memphis, TNNPI 1154369932
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (50.5%), food and beverage and education — rather than concentrated in one kind of arrangement. 28 manufacturers reported payments, led by Boston Scientific at 48.7% of the total. Reporting peaked in 2019 at $2,724 and has fallen 72.2% since, to $757 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in TN, where the typical reported total is $12,690.
Across 183 payments — averaging $37.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- Abbott$927
- Medtronic$900
- Novartis$400
- E.r. Squibb & Sons, L.L.C.$145
- Biotronik Inc.$144
- plus $998 from 22 others
Across 34 payments — averaging $1364.66 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$37K
- Boston Scientific$10K
What the payments were for
- Travel & lodging$3,45550%
- Food & beverage$3,38849%
- Education$50%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 63 | $3,334 |
| Abbott | 8 | $927 |
| Medtronic(2 entities) | 18 | $900 |
| Novartis | 23 | $400 |
| E.r. Squibb & Sons, L.L.C. | 9 | $145 |
| Biotronik Inc. | 1 | $144 |
| Sanofi-aventis U.S. LLC | 9 | $137 |
| Actelion Pharmaceuticals US, Inc. | 10 | $108 |
| Biosense Webster, Inc. | 3 | $91 |
| Boehringer Ingelheim | 4 | $80 |
| AstraZeneca | 4 | $67 |
| Pfizer | 4 | $64 |
| Amgen | 4 | $62 |
| Johnson & Johnson | 4 | $55 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Cordis US CORP. | 1 | $38 |
| Philips North America LLC | 2 | $37 |
| Merck | 2 | $30 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $26 |
| Irhythm Technologies, Inc. | 1 | $23 |
| CSL Behring | 1 | $23 |
| Novo Nordisk | 1 | $21 |
| Cvrx, Inc. | 2 | $20 |
| Vifor Pharma, Inc. | 1 | $20 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $18 |
| Portola Pharmaceuticals, LLC | 1 | $16 |
| Lexicon Pharmaceuticals, Inc. | 1 | $13 |
| G Medical Diagnostic Services, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Watchman$1,273
- AVEIR$694
- Micra$691
- Solia$144
- AMVIA EDGE$144
- Acticor 7 VR-T DX$144
- PAMIRA$144
- BioMonitor$144
- TACTICATH ABLATION CATHETER, SENSOR ENABLED$101
How this compares
$6,847 in reported general payments places this provider in the 35th percentile of 82 clinical cardiac electrophysiology providers in Tennessee.
See all clinical cardiac electrophysiology providers in Tennessee →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 701 | $717,868 |
| XareltoRivaroxaban | 165 | $171,129 |
| MultaqDronedarone Hcl | 69 | $96,722 |
| EntrestoSacubitril/Valsartan | 52 | $61,889 |
| JardianceEmpagliflozin | 43 | $51,208 |
| Repatha SureclickEvolocumab | 21 | $21,877 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 37 | $11,160 |
| BrilintaTicagrelor | 15 | $9,196 |
| Flecainide Acetate | 147 | $8,768 |
| Breo ElliptaFluticasone/Vilanterol | 11 | $4,191 |
| Amiodarone Hcl | 105 | $3,678 |
| Nebivolol Hcl | 41 | $3,606 |
| Diltiazem 12hr ErDiltiazem Hcl | 11 | $3,304 |
| Potassium Chloride | 111 | $3,218 |
| Ranolazine ErRanolazine | 26 | $3,179 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $64 | $717,868701 claims |
| Johnson & JohnsonXarelto | $55 | $171,129165 claims |
| Sanofi-aventis U.S. LLCMultaq | $137 | $96,72269 claims |
| NovartisEntresto | $400 | $61,88952 claims |
| Boehringer IngelheimJardiance | $80 | $51,20843 claims |
| AstraZenecaBrilinta | $67 | $9,19615 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 82 clinical cardiac electrophysiology providers in Tennessee.
Other clinical cardiac electrophysiology in Memphis
- Ikechukwu IfediliMemphis$76K
- Indranill Basu RayMemphis$74K
- Eric JohnsonMemphis$59K
- Rajesh KabraMemphis$42K
- Yehoshua LevineMemphis$37K
- Sunil JhaMemphis$14K
- Karine GuerrierMemphis$7K
- Stephen FahrigNashville$605K
- Gregory BashianNashville$361K
- Harish ManyamChattanooga$265K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.